Which has stronger valuation & earnings, TRNS or AEHR?

Transcat has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Transcat $331.88M 2.61 $5.38M $0.58 159.95 Aehr Test Systems $58.97M 51.23 -$3.91M -$0.38 N/A

Does the media favor TRNS or AEHR?

In the previous week, Aehr Test Systems had 2 more articles in the media than Transcat. MarketBeat recorded 7 mentions for Aehr Test Systems and 5 mentions for Transcat. Aehr Test Systems' average media sentiment score of 0.98 beat Transcat's score of 0.75 indicating that Aehr Test Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aehr Test Systems 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ALNT or TRNS?

Allient has higher revenue and earnings than Transcat. Allient is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Allient $554.48M 3.16 $22.03M $1.43 71.98 Transcat $331.88M 2.61 $5.38M $0.58 159.95

Is ALNT or TRNS more profitable?

Allient has a net margin of 4.25% compared to Transcat's net margin of 1.62%. Allient's return on equity of 12.47% beat Transcat's return on equity. Company Net Margins Return on Equity Return on Assets Allient 4.25% 12.47% 6.37% Transcat 1.62% 5.84% 3.78%

Does the media refer more to ALNT or TRNS?

In the previous week, Transcat had 2 more articles in the media than Allient. MarketBeat recorded 5 mentions for Transcat and 3 mentions for Allient. Transcat's average media sentiment score of 0.75 beat Allient's score of 0.53 indicating that Transcat is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Transcat 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, TRNS or ALMR?

Transcat has higher revenue and earnings than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Transcat $331.88M 2.61 $5.38M $0.58 159.95 Alamar Biosciences $87.16M 21.54 N/A N/A N/A

Does the media prefer TRNS or ALMR?

In the previous week, Transcat had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 5 mentions for Transcat and 3 mentions for Alamar Biosciences. Transcat's average media sentiment score of 0.75 beat Alamar Biosciences' score of 0.63 indicating that Transcat is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Transcat (TRNS) Competitors

$92.77 +1.49 (+1.63%)

Closing price 04:00 PM Eastern

Extended Trading

$92.48 -0.28 (-0.31%)

As of 04:12 PM Eastern

Compare

TRNS vs. AEHR, ALNT, ALMR, EYPT, and FEIM

Should you buy Transcat stock or one of its competitors? MarketBeat compares Transcat with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Transcat include Aehr Test Systems (AEHR), Allient (ALNT), Alamar Biosciences (ALMR), Eyepoint Pharmaceuticals (EYPT), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.

How does Transcat compare to Aehr Test Systems?

Transcat (NASDAQ:TRNS) and Aehr Test Systems (NASDAQ:AEHR) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

In the previous week, Aehr Test Systems had 2 more articles in the media than Transcat. MarketBeat recorded 7 mentions for Aehr Test Systems and 5 mentions for Transcat. Aehr Test Systems' average media sentiment score of 0.98 beat Transcat's score of 0.75 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Transcat	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aehr Test Systems	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Transcat has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.17, suggesting that its stock price is 217% more volatile than the broader market.

Transcat has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$331.88M	2.61	$5.38M	$0.58	159.95
Aehr Test Systems	$58.97M	51.23	-$3.91M	-$0.38	N/A

98.3% of Transcat shares are owned by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are owned by institutional investors. 2.8% of Transcat shares are owned by company insiders. Comparatively, 6.8% of Aehr Test Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Transcat presently has a consensus target price of $105.33, suggesting a potential upside of 13.54%. Aehr Test Systems has a consensus target price of $68.00, suggesting a potential downside of 29.21%. Given Transcat's stronger consensus rating and higher probable upside, equities research analysts plainly believe Transcat is more favorable than Aehr Test Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Aehr Test Systems	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Transcat has a net margin of 1.62% compared to Aehr Test Systems' net margin of -25.23%. Transcat's return on equity of 5.84% beat Aehr Test Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	1.62%	5.84%	3.78%
Aehr Test Systems	-25.23%	-7.15%	-6.15%

Summary

Transcat beats Aehr Test Systems on 11 of the 17 factors compared between the two stocks.

How does Transcat compare to Allient?

Allient (NASDAQ:ALNT) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

In the previous week, Transcat had 2 more articles in the media than Allient. MarketBeat recorded 5 mentions for Transcat and 3 mentions for Allient. Transcat's average media sentiment score of 0.75 beat Allient's score of 0.53 indicating that Transcat is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Transcat	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Allient currently has a consensus price target of $77.33, indicating a potential downside of 24.87%. Transcat has a consensus price target of $105.33, indicating a potential upside of 13.54%. Given Transcat's higher probable upside, analysts clearly believe Transcat is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

61.6% of Allient shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 15.0% of Allient shares are owned by company insiders. Comparatively, 2.8% of Transcat shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Allient has higher revenue and earnings than Transcat. Allient is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	3.16	$22.03M	$1.43	71.98
Transcat	$331.88M	2.61	$5.38M	$0.58	159.95

Allient has a net margin of 4.25% compared to Transcat's net margin of 1.62%. Allient's return on equity of 12.47% beat Transcat's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Transcat	1.62%	5.84%	3.78%

Allient has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market. Comparatively, Transcat has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market.

Summary

Allient beats Transcat on 11 of the 17 factors compared between the two stocks.

How does Transcat compare to Alamar Biosciences?

Transcat (NASDAQ:TRNS) and Alamar Biosciences (NASDAQ:ALMR) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

In the previous week, Transcat had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 5 mentions for Transcat and 3 mentions for Alamar Biosciences. Transcat's average media sentiment score of 0.75 beat Alamar Biosciences' score of 0.63 indicating that Transcat is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Transcat	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Transcat currently has a consensus price target of $105.33, indicating a potential upside of 13.54%. Alamar Biosciences has a consensus price target of $30.00, indicating a potential upside of 10.74%. Given Transcat's higher possible upside, research analysts plainly believe Transcat is more favorable than Alamar Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Transcat has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$331.88M	2.61	$5.38M	$0.58	159.95
Alamar Biosciences	$87.16M	21.54	N/A	N/A	N/A

98.3% of Transcat shares are held by institutional investors. 2.8% of Transcat shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Transcat has a net margin of 1.62% compared to Alamar Biosciences' net margin of 0.00%. Transcat's return on equity of 5.84% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	1.62%	5.84%	3.78%
Alamar Biosciences	N/A	N/A	N/A

Summary

Transcat beats Alamar Biosciences on 10 of the 13 factors compared between the two stocks.

How does Transcat compare to Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ:EYPT) and Transcat (NASDAQ:TRNS) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

Eyepoint Pharmaceuticals presently has a consensus target price of $37.83, suggesting a potential upside of 165.03%. Transcat has a consensus target price of $105.33, suggesting a potential upside of 13.54%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eyepoint Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.00
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. Comparatively, 98.3% of Transcat shares are held by institutional investors. 5.1% of Eyepoint Pharmaceuticals shares are held by insiders. Comparatively, 2.8% of Transcat shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Eyepoint Pharmaceuticals has a beta of 1.72, suggesting that its stock price is 72% more volatile than the broader market. Comparatively, Transcat has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market.

Transcat has a net margin of 1.62% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Transcat's return on equity of 5.84% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eyepoint Pharmaceuticals	-3,566.63%	-110.54%	-90.15%
Transcat	1.62%	5.84%	3.78%

In the previous week, Transcat had 3 more articles in the media than Eyepoint Pharmaceuticals. MarketBeat recorded 5 mentions for Transcat and 2 mentions for Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals' average media sentiment score of 0.94 beat Transcat's score of 0.75 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Eyepoint Pharmaceuticals	Positive
Transcat	Positive

Transcat has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eyepoint Pharmaceuticals	$31.37M	38.15	-$231.96M	-$3.50	N/A
Transcat	$331.88M	2.61	$5.38M	$0.58	159.95

Summary

Eyepoint Pharmaceuticals beats Transcat on 9 of the 17 factors compared between the two stocks.

How does Transcat compare to Frequency Electronics?

Transcat (NASDAQ:TRNS) and Frequency Electronics (NASDAQ:FEIM) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Transcat had 4 more articles in the media than Frequency Electronics. MarketBeat recorded 5 mentions for Transcat and 1 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.89 beat Transcat's score of 0.75 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Transcat	Positive
Frequency Electronics	Very Positive

Frequency Electronics has a net margin of 10.78% compared to Transcat's net margin of 1.62%. Frequency Electronics' return on equity of 12.69% beat Transcat's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	1.62%	5.84%	3.78%
Frequency Electronics	10.78%	12.69%	7.84%

98.3% of Transcat shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 2.8% of Transcat shares are held by insiders. Comparatively, 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Transcat currently has a consensus price target of $105.33, suggesting a potential upside of 13.54%. Frequency Electronics has a consensus price target of $43.67, suggesting a potential downside of 34.19%. Given Transcat's higher possible upside, equities analysts clearly believe Transcat is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Frequency Electronics has lower revenue, but higher earnings than Transcat. Frequency Electronics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$331.88M	2.61	$5.38M	$0.58	159.95
Frequency Electronics	$69.81M	9.35	$23.69M	$0.75	88.47

Transcat has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

Summary

Frequency Electronics beats Transcat on 9 of the 16 factors compared between the two stocks.

Get Transcat News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TRNS vs. The Competition

Export

Metric	Transcat	INSTRU Industry	Computer Sector	NASDAQ Exchange
Market Cap	$852.62M	$3.29B	$38.62B	$12.45B
Dividend Yield	N/A	0.96%	3.30%	6.16%
P/E Ratio	159.95	76.72	171.48	24.87
Price / Sales	2.61	3.88	622.16	102.84
Price / Cash	19.55	27.25	47.85	58.59
Price / Book	2.88	4.41	9.81	6.54
Net Income	$5.38M	$73.46M	$1.07B	$336.70M
7 Day Performance	3.70%	4.10%	2.52%	3.31%
1 Month Performance	9.76%	5.85%	0.31%	1.68%
1 Year Performance	7.92%	68.26%	160.17%	31.96%

Transcat Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TRNS Transcat	3.1971 of 5 stars	$92.77 +1.6%	$105.33 +13.5%	+7.6%	$852.62M	$331.88M	159.95	1,413	Analyst Upgrade
AEHR Aehr Test Systems	1.7003 of 5 stars	$103.65 -8.5%	$68.00 -34.4%	+656.9%	$3.26B	$58.97M	N/A	90	Gap Down
ALNT Allient	3.6635 of 5 stars	$95.56 -3.3%	$77.33 -19.1%	+177.8%	$1.61B	$554.48M	66.36	2,478
ALMR Alamar Biosciences	3.7507 of 5 stars	$22.51 -1.2%	$30.00 +33.3%	N/A	$1.56B	$87.16M	N/A	222
EYPT Eyepoint Pharmaceuticals	2.9131 of 5 stars	$14.17 +3.2%	$31.80 +124.4%	+46.4%	$1.18B	$31.37M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TRNS) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Transcat (TRNS) Competitors

TRNS vs. AEHR, ALNT, ALMR, EYPT, and FEIM

How does Transcat compare to Aehr Test Systems?

Summary

How does Transcat compare to Allient?

Summary

How does Transcat compare to Alamar Biosciences?

Summary

How does Transcat compare to Eyepoint Pharmaceuticals?

Summary

How does Transcat compare to Frequency Electronics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TRNS vs. The Competition

Transcat Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Transcat (TRNS) Competitors

TRNS vs. AEHR, ALNT, ALMR, EYPT, and FEIM

How does Transcat compare to Aehr Test Systems?

Does the media favor TRNS or AEHR?

Which has more risk & volatility, TRNS or AEHR?

Which has stronger valuation & earnings, TRNS or AEHR?

Do insiders & institutionals hold more shares of TRNS or AEHR?

Do analysts rate TRNS or AEHR?

Is TRNS or AEHR more profitable?

Summary

How does Transcat compare to Allient?

Does the media refer more to ALNT or TRNS?

Do analysts recommend ALNT or TRNS?

Do insiders and institutionals have more ownership in ALNT or TRNS?

Which has preferable valuation and earnings, ALNT or TRNS?

Is ALNT or TRNS more profitable?

Which has more risk & volatility, ALNT or TRNS?

Summary

How does Transcat compare to Alamar Biosciences?

Does the media prefer TRNS or ALMR?

Do analysts prefer TRNS or ALMR?

Which has higher earnings & valuation, TRNS or ALMR?

Do insiders & institutionals believe in TRNS or ALMR?

Is TRNS or ALMR more profitable?

Summary

How does Transcat compare to Eyepoint Pharmaceuticals?

Do analysts prefer EYPT or TRNS?

Do insiders & institutionals have more ownership in EYPT or TRNS?

Which has more risk and volatility, EYPT or TRNS?

Is EYPT or TRNS more profitable?

Does the media prefer EYPT or TRNS?

Which has preferable earnings & valuation, EYPT or TRNS?

Summary

How does Transcat compare to Frequency Electronics?

Does the media prefer TRNS or FEIM?

Is TRNS or FEIM more profitable?

Do institutionals and insiders have more ownership in TRNS or FEIM?

Do analysts rate TRNS or FEIM?

Which has preferable valuation and earnings, TRNS or FEIM?

Which has more risk and volatility, TRNS or FEIM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TRNS vs. The Competition

Transcat Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools